vs

Side-by-side financial comparison of CME Group (CME) and Vertiv Holdings Co (VRT). Click either name above to swap in a different company.

Vertiv Holdings Co is the larger business by last-quarter revenue ($2.6B vs $1.9B, roughly 1.4× CME Group). Vertiv Holdings Co runs the higher net margin — 14.7% vs 0.1%, a 14.7% gap on every dollar of revenue. On growth, Vertiv Holdings Co posted the faster year-over-year revenue change (30.1% vs 14.5%). Over the past eight quarters, Vertiv Holdings Co's revenue compounded faster (16.5% CAGR vs 10.8%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

Vertiv is an American multinational provider of critical infrastructure and services for data centers, communication networks, and commercial and industrial environments.

CME vs VRT — Head-to-Head

Bigger by revenue
VRT
VRT
1.4× larger
VRT
$2.6B
$1.9B
CME
Growing faster (revenue YoY)
VRT
VRT
+15.7% gap
VRT
30.1%
14.5%
CME
Higher net margin
VRT
VRT
14.7% more per $
VRT
14.7%
0.1%
CME
Faster 2-yr revenue CAGR
VRT
VRT
Annualised
VRT
16.5%
10.8%
CME

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CME
CME
VRT
VRT
Revenue
$1.9B
$2.6B
Net Profit
$1.2M
$390.1M
Gross Margin
37.7%
Operating Margin
0.1%
Net Margin
0.1%
14.7%
Revenue YoY
14.5%
30.1%
Net Profit YoY
20.7%
137.1%
EPS (diluted)
$0.99

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
VRT
VRT
Q1 26
$1.9B
$2.6B
Q4 25
$1.6B
$2.9B
Q3 25
$1.5B
$2.7B
Q2 25
$1.7B
$2.6B
Q1 25
$1.6B
$2.0B
Q4 24
$1.5B
$2.3B
Q3 24
$1.6B
$2.1B
Q2 24
$1.5B
$2.0B
Net Profit
CME
CME
VRT
VRT
Q1 26
$1.2M
$390.1M
Q4 25
$1.2B
$445.6M
Q3 25
$908.0M
$398.5M
Q2 25
$1.0B
$324.2M
Q1 25
$956.2M
$164.5M
Q4 24
$874.6M
$147.0M
Q3 24
$912.8M
$176.6M
Q2 24
$883.2M
$178.1M
Gross Margin
CME
CME
VRT
VRT
Q1 26
37.7%
Q4 25
38.9%
Q3 25
37.8%
Q2 25
34.0%
Q1 25
33.7%
Q4 24
37.1%
Q3 24
36.5%
Q2 24
38.0%
Operating Margin
CME
CME
VRT
VRT
Q1 26
0.1%
Q4 25
61.8%
20.1%
Q3 25
63.3%
19.3%
Q2 25
66.7%
16.8%
Q1 25
67.5%
14.3%
Q4 24
62.1%
19.5%
Q3 24
64.6%
17.9%
Q2 24
65.3%
17.2%
Net Margin
CME
CME
VRT
VRT
Q1 26
0.1%
14.7%
Q4 25
71.7%
15.5%
Q3 25
59.1%
14.9%
Q2 25
60.6%
12.3%
Q1 25
58.2%
8.1%
Q4 24
57.3%
6.3%
Q3 24
57.6%
8.5%
Q2 24
57.6%
9.1%
EPS (diluted)
CME
CME
VRT
VRT
Q1 26
$0.99
Q4 25
$3.24
$1.14
Q3 25
$2.49
$1.02
Q2 25
$2.81
$0.83
Q1 25
$2.62
$0.42
Q4 24
$2.40
$0.38
Q3 24
$2.50
$0.46
Q2 24
$2.42
$0.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
VRT
VRT
Cash + ST InvestmentsLiquidity on hand
$2.4B
$2.5B
Total DebtLower is stronger
$3.4B
$0
Stockholders' EquityBook value
$4.2B
Total Assets
$202.0B
$13.4B
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
VRT
VRT
Q1 26
$2.4B
$2.5B
Q4 25
$4.5B
$1.7B
Q3 25
$2.6B
$1.4B
Q2 25
$2.1B
$1.6B
Q1 25
$1.5B
$1.5B
Q4 24
$3.0B
$1.2B
Q3 24
$2.4B
$908.7M
Q2 24
$1.9B
$579.7M
Total Debt
CME
CME
VRT
VRT
Q1 26
$3.4B
$0
Q4 25
$2.9B
Q3 25
$2.9B
Q2 25
$2.9B
Q1 25
$2.9B
Q4 24
$2.9B
Q3 24
$2.9B
Q2 24
$2.9B
Stockholders' Equity
CME
CME
VRT
VRT
Q1 26
$4.2B
Q4 25
$28.7B
$3.9B
Q3 25
$28.2B
$3.5B
Q2 25
$27.7B
$3.1B
Q1 25
$27.0B
$2.7B
Q4 24
$26.5B
$2.4B
Q3 24
$28.2B
$1.8B
Q2 24
$27.6B
$1.5B
Total Assets
CME
CME
VRT
VRT
Q1 26
$202.0B
$13.4B
Q4 25
$198.4B
$12.2B
Q3 25
$187.1B
$10.8B
Q2 25
$179.9B
$10.4B
Q1 25
$157.8B
$9.5B
Q4 24
$137.4B
$9.1B
Q3 24
$137.8B
$8.9B
Q2 24
$123.4B
$8.1B
Debt / Equity
CME
CME
VRT
VRT
Q1 26
0.00×
Q4 25
0.74×
Q3 25
0.83×
Q2 25
0.93×
Q1 25
1.10×
Q4 24
1.20×
Q3 24
1.62×
Q2 24
1.91×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
VRT
VRT
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$652.8M
FCF MarginFCF / Revenue
24.6%
Capex IntensityCapex / Revenue
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$2.3B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
VRT
VRT
Q1 26
Q4 25
$1.1B
$978.9M
Q3 25
$968.1M
$508.7M
Q2 25
$1.1B
$322.9M
Q1 25
$1.1B
$303.3M
Q4 24
$1.0B
$425.2M
Q3 24
$1.0B
$378.2M
Q2 24
$776.9M
$378.4M
Free Cash Flow
CME
CME
VRT
VRT
Q1 26
$652.8M
Q4 25
$1.1B
$885.6M
Q3 25
$949.7M
$463.5M
Q2 25
$1.0B
$277.9M
Q1 25
$1.1B
$266.8M
Q4 24
$991.7M
$364.5M
Q3 24
$973.2M
$341.8M
Q2 24
$758.7M
$344.3M
FCF Margin
CME
CME
VRT
VRT
Q1 26
24.6%
Q4 25
66.8%
30.8%
Q3 25
61.8%
17.3%
Q2 25
61.5%
10.5%
Q1 25
67.1%
13.1%
Q4 24
65.0%
15.5%
Q3 24
61.4%
16.5%
Q2 24
49.5%
17.6%
Capex Intensity
CME
CME
VRT
VRT
Q1 26
4.2%
Q4 25
2.0%
3.2%
Q3 25
1.2%
1.7%
Q2 25
1.1%
1.7%
Q1 25
0.9%
1.8%
Q4 24
1.7%
2.6%
Q3 24
1.9%
1.8%
Q2 24
1.2%
1.7%
Cash Conversion
CME
CME
VRT
VRT
Q1 26
Q4 25
0.96×
2.20×
Q3 25
1.07×
1.28×
Q2 25
1.03×
1.00×
Q1 25
1.17×
1.84×
Q4 24
1.16×
2.89×
Q3 24
1.10×
2.14×
Q2 24
0.88×
2.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons